DRIO (DarioHealth) Float Percentage Of Total Shares Outstanding: 97.20% (As of Jul. 03, 2026)


DRIO DarioHealth Corp DRIO
58 GF Score
Price $7.26
GF Value $7.09
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Float Percentage Of Total Shares Outstanding?

DarioHealth DRIO +7.85% 58 Float Percentage Of Total Shares Outstanding is 97.20% as of Jul. 03, 2026. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.09 (Fairly Valued). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DarioHealth's float shares is 7.11 Mil. DarioHealth's total shares outstanding is 7.31 Mil. DarioHealth's float percentage of total shares outstanding is 97.20%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DarioHealth's Insider Ownership is 54.68%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DarioHealth's Institutional Ownership is 12.88%.

DRIO
58GF Score
DarioHealth Corp DRIO
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DarioHealth Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

DarioHealth's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=7.11/7.31
=97.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 97.20% mean?
DarioHealth (DRIO) has a Float Percentage Of Total Shares Outstanding of 97.20% as of Jul. 03, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on DarioHealth and its competitors.
Is DarioHealth's Float Percentage Of Total Shares Outstanding too high?
DarioHealth's current Float Percentage Of Total Shares Outstanding is 97.20%. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Float Percentage Of Total Shares Outstanding compare to BEAT and ONMD?
DarioHealth's Float Percentage Of Total Shares Outstanding of 97.20% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Healthcare Providers & Services company?
A good Float Percentage Of Total Shares Outstanding depends on the Healthcare Providers & Services industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on DarioHealth and its competitors. DarioHealth's current Float Percentage Of Total Shares Outstanding is 97.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.09, compared to a current price of $7.26 — trading 2.3% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 97.20%. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For DarioHealth (DRIO), the current Float Percentage Of Total Shares Outstanding is 97.20% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.26 is trading 2.3% above its estimated GF Value™ of $7.09. GuruFocus considers DarioHealth to be Fairly Valued.

Key valuation signals for DRIO:

  • Float Percentage Of Total Shares Outstanding: 97.20%
  • GF Value™: $7.09 vs. price of $7.26 (2.3% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
58GF Score

Get the complete analysis for DRIO

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.26
Price
$7.09
GF Value